📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

ERK5 Signalling and Resistance to ERK1/2 Pathway Therapeutics: The Path Less Travelled? (2022)

First Author: Cook S

Attributed to: Defining the role of ERK5 kinase and ERK5 transcriptional activities in cell migration and EMT using novel ERK5 inhibitors funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fcell.2022.839997

PubMed Identifier: 35903549

Publication URI: http://europepmc.org/abstract/MED/35903549

Type: Journal Article/Review

Parent Publication: Frontiers in Cell and Developmental Biology

ISSN: 2296-634X